# Army Develops Shelf-Stable Biosurveillance Reagents

The U.S. Army is developing room-temperature, shelf-stable reagents for its Far-Forward Biological Sequencing (FFBS) and Non-targeted Sequencing Identification System (NSIS) capabilities to remove cold-chain constraints in field use. The proof of concept is about halfway complete. No solicitation, contract award, funding amount, or deployment date has been identified, so this is a developing capability rather than an active procurement opportunity.

- Suppliers with expertise in reagent stabilization, lyophilization, vitrification, sequencing, or field-ready packaging may find relevant opportunities as the effort advances.
- The development points to a need for sequencing materials that remain stable in austere environments and support far-forward biosurveillance without cold-chain logistics.
- Companies can assess whether their products or technical capabilities align with FFBS and NSIS needs; the signals do not identify a solicitation or a specific procurement timeline.

**Jurisdictions:** federal
**Industries:** Defense & Military
**Topics:** Emergency Response
**Published:** November 05, 2026

### Government Entities
- U.S. Army (Army)
- U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM Chemical Biological Center)
- Joint Project Manager for CBRN Special Operations Forces (JPM CBRN SOF)

### Key Quotes
> Reagent vitrification solves a critical operational bottleneck. Eliminating cold-chain logistics ensures reagents remain stable in austere environments, broadens far-forward deployment and significantly lowers program lifecycle sustainment costs across the force.
> — Ashley Sperry, Assistant Program Manager, JPM CBRN SOF

### Sources
- [Out with the Cold: expanding biosurveillance capability through shelf stable products](https://www.army.mil/article-amp/296583/out_with_the_cold_expanding_biosurveillance_capability_through_shelf_stable_products) - Army.mil